Short answer · Medically reviewed summary · Last updated: 2026-05-08
Bronchomalacia is a structural condition characterized by the weakness of the bronchial walls, leading to airway collapse during expiration. While first identified in the mid-20th century, our understanding of Bronchomalacia has shifted from viewing it as a rare pediatric anomaly to recognizing it as a complex, often underdiagnosed condition affecting both children and adults. When was Bronchomalacia first identified? The medical literature began formally documenting Bronchomalacia in the 1950s and 1960s, often described in pediatric patients who presented with persistent wheezing or recurrent respiratory infections that did not respond to standard asthma treatments.
Bronchomalacia is a structural condition characterized by the weakness of the bronchial walls, leading to airway collapse during expiration. While first identified in the mid-20th century, our understanding of Bronchomalacia has shifted from viewing it as a rare pediatric anomaly to recognizing it as a complex, often underdiagnosed condition affecting both children and adults.
The medical literature began formally documenting Bronchomalacia in the 1950s and 1960s, often described in pediatric patients who presented with persistent wheezing or recurrent respiratory infections that did not respond to standard asthma treatments. Early researchers, such as Holinger and others, utilized rudimentary bronchoscopic techniques to observe the dynamic collapse of the airways, distinguishing Bronchomalacia from other causes of airway obstruction like foreign bodies or extrinsic compression.
Historically, Bronchomalacia was often misdiagnosed as "refractory asthma" because both conditions share symptoms like wheezing and air trapping. Through the late 20th century, the evolution of high-resolution imaging and dynamic airway evaluation allowed clinicians to see that the issue was not bronchial constriction (as in asthma), but rather the structural flaccidity of the cartilage itself. Modern technology, including virtual bronchoscopy and 3D airway reconstruction, has revolutionized our ability to map the extent of Bronchomalacia in the lungs.
Treatment approaches for Bronchomalacia have transitioned from "wait and see" to targeted interventions. Key milestones include:
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.